Immune to Cancer: The CRI Blog
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.
-
ASCO20 Update: Considerations for Checkpoint Inhibitors Moving Forward
Results unveiled at ASCO20 increased our understanding of checkpoint immunotherapy in a variety of cancers and circumstances.
-
ASCO20 Update: Cellular Immunotherapies, Genomics, and COVID-19
Several promising cellular immunotherapies were discussed at ASCO20, including those for solid cancers; plus updates on the cancer…
-
Investigating the Innate Immune Receptor NLRP6 with Dr. Chen Shen
CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and…
-
Building a Single-Cell Atlas with Dr. Ansuman Satpathy
Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or…
-
An Epic Podcast Fundraiser for Cancer Research Returns for a Fourth Year
While many are adjusting to virtual fundraisers at the moment, the Epic Film Guys now have plenty…
-
Four Virtual Fundraising Ideas for Cancer Immunotherapy Month
Host your own themed event and raise money to fuel cancer immunotherapy research.
-
Skin Cancer Awareness Month: 2020 Immunotherapy Research Update
The changing treatment landscape, new scientific research, and how we’re working toward a future immune to skin…
-
Bladder Cancer Awareness Month: 2020 Immunotherapy Research Update
A changing treatment landscape, new scientific research, and how we’re working toward a future immune to bladder…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.